The surge in funding for biologic innovator drugs is attributed to the enactment of IRA According to a recent report by GlobalData, biotechnology companies in the United States have secured significantly more venture financing for biologic innovator drugs compared to small molecule innovator drugs. The analysis reveals that from 2018…
Read More